by Amy Berger | Apr 11, 2025 | News, Publications and Press
Our team is proud to share the promising news from multiple sponsors of recent IITRI in vivo studies. Links below to recent publications. Congrats all! New Sponsor Publication from Mouse Influenza Studies at IITRI: Intranasal administration of a panreactive...
by Amy Berger | Dec 10, 2024 | News, Publications and Press
Check Out Recent IITRI Mentions and Co-authored Publications Below! NPJ Vaccines Boosting neuraminidase immunity in the presence of hemagglutinin with the next generation of influenza vaccines Published Nov 19, 2024. MDPI Vaccines Intranasal M2SR and BM2SR Vaccine...
by Amy Berger | Dec 22, 2022 | News, Publications and Press
IITRI is proud to share recent accomplishments from two of our technical divisions. Several members of our Microbiology and Molecular Biology Division authored a recent publication entitled “Characterization of Three Variants of SARS-CoV-2 In Vivo Shows...
by Amy Berger | Oct 26, 2022 | News, Publications and Press
IITRI is happy to share the promising news of one of our Sponsors, Ascletis Pharma, Inc. They just announced the Investigational New Drug (IND) application of ASC10, an oral antiviral drug candidate targeting viral polymerase of monkeypox virus, has been filed with...
by Amy Berger | Sep 23, 2022 | News, Publications and Press
IITRI is happy to share the good news from our collaboration with the National Cancer Institute (NCI) on their program focusing on an inhaled drug against SARS-CoV-2. Our team here at IITRI was contracted to perform toxicology studies for their drug...
by Amy Berger | Apr 19, 2022 | News, Publications and Press
IITRI is happy to share the promising news of one of our Sponsors, Ascletis Pharma, Inc. Our team here at IITRI was contracted to perform in vitro testing of their drug candidates for antiviral effects against multiple strains of SARS-CoV-2 as well as cytotoxicity....
Recent Comments